This article is concerned with the extension of the Renkin-Crone model to a case of saturable trans port across the blood-brain barrier, i,e., when the ap parent permeability-surface area product is concentration dependent. A well-mixed tissue compartment is assumed, together with a simple symmetric saturable transport system. A computation scheme, or algorithm. is de· scribed that allows the calculation of arteriovenous dif ferences and net influx rates for parent substance and Abbreviation used: PS, permeability-surface area. 386 tracer in terms of arterial and tissue concentrations of each, the transport maximum T max' the half-saturation constant Kt• and plasma flow rate. The scheme was de vised initially for the analysis of experiments in which the parent substance was not in a steady state and in which tracer backflux from tissue to capillary was significant.
The design and analysis of experiments in which tracers are used to measure rates of transport of substances across the blood-brain barrier and to estimate associated rate constants are often based on extensions of the Renkin-Crone model (Renkin. 1959; Crone, 1963) . This model relates the arterio venous extraction of plasma-borne labeled sub stances that cross the capillary walls by nonfacili tated diffusion to the plasma flow rate and to a permeability-surface area (PS) product. The ex trapolation from the behaviour of the tracer to that of the parent substance involves, in general, mea surement of a specific activity at some point(s) within the system, often in the arterial plasma. At tention has been drawn to an important phenom enon in this respect (Gjedde, 1980; Christensen et al., 1982) , namely, that under conditions where the backflow of parent substance from brain tissue to plasma is significant, the mean capillary plasma specific activity will usually differ from that in the arterial plasma. This effect is noticeable, for ex ample, when short-term techniques are employed to trace an endogenous substance, and failure to take it into account may lead to a significant un derestimation of the rate of transfer of parent sub stance from plasma to tissue.
This article is concerned with the extension of the model to the analysis of saturable transport across the blood-brain barrier. In this case, the transport of the parent substance is not first order, but varies between zero and first order, and the apparent PS product is concentration dependent. The simplest interpretation of the variation of the apparent PS product with the concentration of the parent substance is in terms of a transport max imum T max and a concentration K( at which unidi rectional transport is half-maximal.
Previous analyses of the behaviour of parent sub stance and tracer under saturable transport condi tions have involved approximations that have been justified by the particular experimental design being considered. Thus, for example, Gjedde (1980) has analysed blood-brain glucose transport based on a steady-state model and a time course in which back flux of tracer from brain to blood was considered negligible. Christensen et al. (1982) have also ana lysed glucose transport, again when the backflux of tracer but not parent substance could be ignored. In both these cases, a treatment analogous to that of Crone (1963) was applied to the tracer to obtain an apparent PS product for any given steady state of parent substance. Strictly, even within the con fines of the simple model, the behaviour of tracer should be related to the integral of the PS product times the tracer concentration profile within the capillary as the PS product would itself vary with the concentration of the parent substance along the capillary. Gjedde (1980) , however, showed the steady-state fall in glucose concentration along the capillary to be small and based estimates of the ki netic constants on the relationship between thc ap parent PS product and the arterial concentration of parent substance. Christensen et al. (1982) based estimates on capillary concentrations taken as the arithmetic mean of arterial and venous concentra tions and justified the approximation with reference to separate numerical estimates of the integral.
An alternative approach to the analysis of this model is presented here. It was undertaken initially to estimate T max and Kt for glucose transport across the blood-brain barrier under conditions where several of the above assumptions did not hold, in particular, those relating to the steady state of parent substance and the absence of tracer backflux (Hargreaves et aI., 1985) . A simple undistributed model involving a well-mixed tissue compartment is assumed, which communicates with the capillary plasma via a symmetrical carrier system composed of a single saturable component in each direction with no nonfacilitated diffusion. Assumptions re garding the effective constant mean capillary con centration are avoided, and the integral along the capillary is evaluated. The approach has been to develop an algorithm to allow the computation of the instantaneous arteriovenous differences, and hence net influx rates, of both parent substance and tracer in terms of their respective arterial and tissue concentrations and of a T max' Kt, and plasma flow rate.
It is emphasized that this article is concerned principally with the calculation of net influx rates and that the variations with time of the parent sub stance and the tracer in the tissue will be functions not only of net influx rates but also of other terms such as the rate of metabolic loss from the tissue pool. Application of these equations to simulation or the analysis of experimental data would therefore require integration with respect to time. Intcgra tion, particularly in the nonsteady state, will require a numerical integration procedure. The computa tions given in this report have therefore been sum marised in the Appendix as a short computer sub routine with a view to its inclusion in such a pro cedure.
THEORY
The development of the equations will be pre sented in four stages. Stages I and II refer to the parent substance only. Stage I considers a situation in which the parent substance passes from capillary to tissue with no return. This situation is presented to introduce a numerical technique (see Appendix) that is also necessary in Stage II. In Stage II, the transport of parent substance from tissue to capil lary is also taken into account. Stages III and IV include the movement of tracer superimposed on the conditions of Stage II. Stage III considers the situation in which the backflux of tracer is negligible and Stage IV that in which tracer backflux is sig nificant.
Stage I
Let C(x) be the concentration of parent substance in a small element of plasma at a fractional distance x from the arterial end of a capillary of arbitrary length such that x = 0 at the arterial end and x = I at the venous end. If the substance is transported out of the capillary via a transporter with constants T max and Kt and if there is no return of the substance from tissue to capillary, then at plasma flow rate F,
[see formulations of Gjedde (1980) 
where CA and CV are the concentrations of the parent substance at the arterial and venous ends, respectively. Equation 2 cannot be rearranged simply to give (CA -CV), the arteriovenous dif ference, explicitly in terms of CA, F, T max ' and Kt· However, CV may be calculated simply and to any required accuracy using a Newton-Raphson tech nique on Eq. 2 (see Appendix). The instantaneous net rate of influx of parent substance Do lins t is then given by
A more general case, which applies from now on, involves the parent substance in a single tissue com partment at concentration CT. CT is assumed con stant throughout the (negligible) time of transit of a single element of plasma through the capillary, and hence
which has the solution (5) to x and a substitution based on Eq. 5.) Then putting Q(O) = QA and Q(1) = QV,
where QA and QV are the concentrations of tracer
It will be seen that Eq. 2 is a special case of Eq. 6, with CT = O. Again, Eq. 6 cannot be rearranged simply to give an explicit expression for CV in terms of CA, CT, Kp T max' and F. However, CV may again be calculated efficiently using a Newton Raphson technique (see Appendix). The instanta neous net rate of influx of the parent substance is then given by Eq. 3.
Stage III
Consider the introduction of tracer into the system such that its concentration is Q(x) at frac tional distance x from the arterial end of the capil lary. The tracer concentration is negligible com pared with C(x) , but the transport of tracer from plasma to tissue is a function of C(x), T max ' and Kt.
at the arterial and venous ends, respectively. Equa tion IO allows QV to be expressed explicitly in terms of CA, CT, CV, QA, and Kt; CV being ob tained as described above.
The instantaneous net influx of tracer from plasma to tissue �J;nst is then given by
Consider a situation in which the backflux of tracer from tissue to plasma is significant. The con centration of tracer in the tissue QT is assumed con stant throughout a single capillary passage. Back flux of tracer is a function of QT, CT, T max ' Kp and F such that
Assuming for the moment that no backflux of tracer occurs, then
Integration of Eq. 7 gives
In Q(x) = -T max .
The expression on the right-hand side of Eq. 8 is equal to
where I is a constant of integration. (This may be checked by differentiating expression 9 with respect J Cereb Blood Flow Metabol, Vol. 5, No.3, 1985 Equation 12 is not amenable to solution in the same manner as the preceding stages. However, the fol lowing approach to obtaining the arteriovenous dif ference for tracer (QA -QV) may be taken.
It is convenient to consider the parent substance in the plasma, concentration C(x), as composed of two populations, one originating in the arterial plasma and remaining in the plasma at concentra tion P(x), the other having derived from the well mixed tissue compartment, its concentration in the plasma being B(x). The rate of change of both P(x) and B(x) is, however, a function of the total con centration C(x) such that 
CA -CT Kt
Let the concentration of parent substance at the venous end that has mixed with the tissue com partment during passage be denoted BV. Then, BV = CV -PV Finally, if the specific activity at the arterial end is QAICA and that in the tissue is QTICT, then the concentration of tracer at the venous end QV is given by
and the instantaneous net rate of uptake of label is again given by Eq. 11.
DISCUSSION
A scheme has been described that allows the computation of the rates of net influx for a parent substance and tracer, transported across the blood brain barrier via a saturable system, in terms of arterial plasma and tissue concentrations, kinetic constants, and plasma flow rate. Within the con fines of the simple model, the scheme accommo dates the separate concentration profiles of parent substance and tracer within the capillary. This scheme may be implemented as a short computer subroutine as described in the Appendix. The model on which it is based is undoubtedly a sim plification of the physiological reality, but is widely used and has been productive experimentally. It is, however, limited in that only a single component of saturable transport is considered and that a nonfa cilitated diffusion term is not included. It is also limited in that the model on which it is based is undistributed. There are several features of the po tential paths through the tissue of an element of plasma that might be expected to have associated probability distributions. These would include transit time and transporter density. The nonlinear properties of the system mean that failure to take such heterogeneity into account may introduce bias from the use of mean values (see Bass et al. , 1983) , and the model is presented with this qualification.
The presentation refers to instantaneous rates of net influx of parent substance linst and of tracer lins!' since the time of a single pass through the capillary is considered negligible and it is intended that the subroutine be incorporated in a numerical routine to perform integration with respect to real time. Although this approach does not allow for more elegant explicit expressions for the time in tegrals, its particular advantage is that nonsteady states for both parent substance and tracer can be modelled. In this context, t::. linst and M inst are con sidered as functions of time, t::. l(t) and M *(t), re spectively, their values at any point in time being calculable in terms of the corresponding values of CA, CT, etc. , as described in the computation scheme.
The approach described here has been applied to the estimation of T max and Kt for glucose transport across the blood-brain barrier (Hargreaves et al. , 1985) using a programmed infusion technique (Daniel et al., 1978) with a view to correcting for tracer backflux on a background of changing tissue glucose content. Data were obtained on accumu lated tracer in regions of brain in the rat after de fined infusions of cold and labelled glucose, and a preliminary analysis had shown non saturable up take insignificant. Independent estimates were available from rats in the same physiological state of plasma flow rate, CMRG, and brain glucose con tent in brain regions prior to the start of the infu sions. Plasma flow rate and CMRG were assumed constant throughout the time course of the experi ment (up to 1 min 45 s). The variations of brain glucose content and of total brain tracer content after the start of the infusions were modelled where the brain glucose content M(t) and tracer content M*(t) are related to CT and QT, their re spective tissue concentrations, by an assumed (real) distribution volume. The metabolic rate of loss of tracer glucose CMRG* may be obtained from CMRG and the tissue glucose specific activity. Label in metabolic products P*(t) is assumed to ac cumulate without loss. These equations were inte grated numerically. !::. lU) and !::. J*(t) are in turn func tions of T max and Kt (see computation scheme), and the latter were varied in an optimization routine to obtain a least means squares fit to the total available data.
In the above application of the computation scheme, data were available over a wide range of arterial concentrations of parent substance and hence the kinetic constants T max and Kt could be estimated. It is often the case, however, that studies are made in a particular animal or in a physiological state where the range of concentrations is limited.
Here it is usually the rates themselves that are of interest rather than necessarily their use to estimate kinetic constants. In such cases, the scheme pre sented here to allow more complete treatments, al beit of a simple model, is not appropriate unless, for example, Kt is known. Net rates of influx would then be interpreted in terms of an equivalent T max at any given arterial concentration and flow rate. Alternatively, if a steady state pertains for the parent substance and if its concentration does not change greatly within the capillary, then the system may be treated, with minor approximation, in terms of apparent PS products and effective mean con centrations. Since in general the tissue concentra tion of parent substance will differ from the mean capillary concentration, then even with a symmet rical transport system, the apparent PS product for influx may differ from that for efflux. Gjedde (1982) gives a derivation of rate equations incorporating tracer backflux under these conditions. Cun ningham and Cremer (1981) have described a method based on the use of labelled 2-deoxyglucose in the steady state to obtain simultaneous estimates of the rates of influx and phosphorylation of glucose in regions of rat brain. Their analysis, however, ef-appropriate analysis would take into account plasma flow rate (if known) based on equations equivalent to that of Eq. 12 of Gjedde (1982) .
In the absence of a steady state for parent sub stances transported via a saturable mechanism or in cases where the arteriovenous extraction of parent substance is high, the quantitative signifi cance of experimental approximations is often dif ficult to assess. The present computation scheme will allow for simulations to help in such sensitivity analyses.
APPENDIX
The purpose of the computation scheme in the main section of this article is to obtain arteriove nous differences for parent substance and tracer in terms of arterial plasma and tissue concentrations, kinetic constants, and plasma flow rate. However, Eqs. 2 and 6 cannot be rearranged simply into ex plicit expressions for the venous plasma concentra tion of parent substance CV. Subsequent compu tation of the instantaneous rates of net influx of parent substance li n st and tracer li n st are based on CV. CV may, however, be calculated efficiently and to any required accuracy within machine limits using a Newton-Raphson iterative technique.
This technique applies to equations of the form
Given a suitable starting value Xo, as an approx imate solution, subsequent iterations (n) are de fined by
where f'(X n ) denotes the derivative of f(x), with respect to X, at X n . Applying this to Eq. 2 with X = CV,
CV may be obtained likewise from Eq. 6, in which case
fectively assumes that the specific activity-time in tegral in arterial plasma equals that in the capillary. Whereas this approximation is reasonable for glu cose over the time period involved (�3 min), a more E KI NSAT (CA,CT,QA,QT,F,TMAX,KT,TERM These equations may be implemented simply in Fortran as shown in the subroutine (Table 1) . Gen erally, values for CV reproducible to within four or five significant figures are produced within a few iterations. Examples are given in Ta ble 2.
The subroutine also incorporates Stage IV of the main presentation. It takes as arguments CA, CT, QA, QT, F, T max -and Kp and returns I:l.J inst and I:l.Jinst (as DJ and DJSTAR). The argument TERM dictates the accuracy within which CV is computed. The argument LIMIT is used to limit the potential number of Newton-Raphson iterations and is dec remented on each iteration. It should therefore be checked on leaving the subroutine, because if it is zero, CV may not have been calculated to within TERM. It was assumed in writing the subroutine that CA would be greater than CT. An initial value for CV is generated assuming first-order kinetics and an apparent PS product based on CA. This will be an initial overestimate and hence if close to CT, iterations are not carried out. A condition is in cluded to avoid occasional intermediate negative values for (CV -Cn.
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